S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ZYNE Zynerba Pharmaceuticals Inc

1.30

0.00 (0.00%)

Pre Market

Last Updated: 19:00:00

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Zynerba Pharmaceuticals Charts.

Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Zynerba Pharmaceuticals Charts.

Zynerba Pharmaceuticals Inc News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 8 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Thursday 19 October 2023 (8 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 11 October 2023 (8 months ago) • Edgar (US Regulatory)

More Zynerba Pharmaceuticals Inc News Articles

Cann American (CE)

ERHC Energy (CE)

Virexit Technologies (PK)

Hannover House (PK)

Digital Brand Media and ... (PK)

Rennova Health (PK)

Ronn Motor (PK)

Elite Pharmaceuticals (QB)

Anavex Life Sciences

CTR Investments and Cons... (PK)

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

SMC Entertainment (PK)

Trump Media and Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions